Results 171 to 180 of about 7,739 (261)

Spinal anesthesia in a patient with Fabry disease and multiorgan involvement: a rare case with long-term success. [PDF]

Am J Transl Res
Kim HT, Bae JH, Shin YD, Park JW, Jeong SJ, Lee JY.   +5 more
europepmc   +1 more source

Reaccumulation of globotriaosylceramide in podocytes after agalsidase dose reduction in young Fabry patients

Nephrology, Dialysis and Transplantation, 2016
R. Skrunes, E. Svarstad, Kristin Kampevold Larsen, S. Leh, C. Tøndel   +4 more
semanticscholar   +1 more source

Systemic metabolic reprogramming and microbial dysbiosis in Fabry disease: Multi-omics mechanisms and implications for drug development. [PDF]

Front Pharmacol
Gómez-Cebrián N, Trull MC, Gras-Colomer E, Edo Solsona MD, Poveda Andrés JL, Puchades-Carrasco L.   +5 more
europepmc   +1 more source

AB077. Identification of lysosomal and extralysosomal globotriaosylceramide (Gb3) accumulation in endomyocardial biopsies before the occurrence of typical pathological changes of Fabry disease

, 2017
Dau‐Ming Niu, Ming-Jia Hsu, Fu‐Pang Chang, Yung-Hsiu Lu, Sheng‐Che Hung, Yu-Chen Wang, An‐Hang Yang, Chia‐Lin Hsu   +7 more
openalex   +1 more source

How should kidney injury in Fabry disease be assessed and monitored? [PDF]

Kidney Res Clin Pract
Song SH.
europepmc   +1 more source

Case report of concurrent Fabry disease and amyotrophic lateral sclerosis supports a common pathway of pathogenesis. [PDF]

, 2016
Beer, A.M., Brown-Wright, S.H., Cooper-Knock, J., Fletcher, S., Nandakumar, T.P., Shaw, P.J.   +5 more
core   +1 more source

The Role of Kidney Biopsy in Fabry Disease. [PDF]

Biomedicines
Capelli I, Martano L, Berti GM, Vischini G, Lerario S, Donadio V, Incensi A, Aiello V, Ciurli F, Fabbrizio B, Chilotti S, Mignani R, Pasquinelli G, La Manna G.   +13 more
europepmc   +1 more source

Investigation of correlation of urinary globotriaosylceramide (Gb3) levels with markers of renal function in patients with Fabry disease.

Clinica chimica acta; international journal of clinical chemistry, 2018
A. P. Moura, T. Hammerschmidt, M. Deon, R. Giugliani, C. Vargas   +4 more
semanticscholar   +1 more source

Glycosphingolipids and their impact on platelet activity in a murine model of fabry disease. [PDF]

Sci Rep
Kanack AJ, Prodoehl E, Ishihara-Aoki M, Aoki K, Dahms NM.   +4 more
europepmc   +1 more source

Molecular Pathogenesis of Central and Peripheral Nervous System Complications in Anderson-Fabry Disease. [PDF]

Int J Mol Sci, 2023
Tuttolomondo A, Baglio I, Riolo R, Todaro F, Parrinello G, Miceli S, Simonetta I.   +6 more
europepmc   +1 more source